1. Home
  2. WCN vs RMD Comparison

WCN vs RMD Comparison

Compare WCN & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waste Connections Inc.

WCN

Waste Connections Inc.

HOLD

Current Price

$159.99

Market Cap

41.9B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$229.44

Market Cap

34.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WCN
RMD
Founded
1997
1989
Country
Canada
United States
Employees
N/A
N/A
Industry
Power Generation
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.9B
34.0B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
WCN
RMD
Price
$159.99
$229.44
Analyst Decision
Buy
Buy
Analyst Count
19
10
Target Price
$204.21
$292.56
AVG Volume (30 Days)
810.6K
1.2M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
0.85%
1.13%
EPS Growth
74.48
9.67
EPS
2.02
10.43
Revenue
$9,466,915,000.00
$2,957,013,000.00
Revenue This Year
$6.14
$10.60
Revenue Next Year
$6.18
$7.41
P/E Ratio
$79.08
$20.93
Revenue Growth
6.14
13.44
52 Week Low
$146.89
$180.27
52 Week High
$179.74
$284.87

Technical Indicators

Market Signals
Indicator
WCN
RMD
Relative Strength Index (RSI) 42.54 48.96
Support Level $154.57 $218.39
Resistance Level $172.77 $233.75
Average True Range (ATR) 2.45 5.92
MACD -0.57 -2.43
Stochastic Oscillator 31.04 28.01

Price Performance

Historical Comparison
WCN
RMD

About WCN Waste Connections Inc.

Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: